Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from two pivotal phase 3 trials evaluating retatrutide, an investigational, first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist
Cohen and A
Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid
Though commonplace for many people, birth control is a complex process that requires careful follow-through
Thymulin-Zinc for immunomodulation affecting follicle health
Drug establishments are required to provide the FDA with a current list of all drugs manufactured, prepared, propagated, compounded or processed for sale in the U.S